Louise Wilson-English

PCI Pharma Services announces US$1 billion expansion of US sterile fill-finish and drug-device delivery combination capabilities

ImmunoForge to accelerate central nervous system drug development with innovative blood-brain barrier shuttle platform

Novo Nordisk to seek oral sickle cell therapy approval after phase 3 success

AI Drug Discovery & Development Summit (AIDDD)

Global Drug Delivery and Formulation (DDF) Summit

Chemspec Europe reveals new details about 2026 conference programme

Dayspring Pharma announces phase 2 trial of CG2001 foam met primary endpoint in Chinese adult men with androgenetic alopecia

PlaqueTec secures $5 million financing to advance drug discovery

Expanded antibody portfolio enhances detection of biologics and therapeutics for bioanalytical applications

AstraZeneca to seek accelerated approval of Ultomirisin in immunoglobulin A nephropathy on phase 3 data